Skip to main content

Table 1 Clinical pathological parameters of patients with breast cancer in this study

From: Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients

 

TCGA cohort

No. of patients

1076

Age (median)

58

Sex (%)

 Female

1076 (100%)

 Male

0 (0%)

Stage/grade (%)

 I/1

183 (17%)

 II/2

608 (56.5%)

 III/3

242 (22.5%)

 IV

20 (1.9%)

 Unknown

23 (2.1%)

ER status (%)

 Positive

806

 Negative

240

 Unknown

30

PR status (%)

 Positive

698

 Negative

345

 Unknown

33

Her2 status (%)

 Positive

161

 Negative

564

 Unknown

351

Therapy

 Chemotherapy

490

 Immunotherapy

4

 Hormone Therapy

269

 Targeted Molecular therapy

5

 Other

308

Survival status OS days (median)

1256